Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

20559-55-1

Oxibendazole

20559-55-1
53716-50-0

Oxfendazole

53716-50-0
1017241-36-9

Olanzapine Thiolactam Impurity

1017241-36-9
1949-20-8

Oxolamine citrate salt

1949-20-8
1017241-34-7

Olanzapine Lactam Impurity

1017241-34-7
6197-30-4

Octocrylen

6197-30-4
26095-59-0

Otilonium bromide

26095-59-0
144689-63-4

Olmesartan Medoxomil

144689-63-4
1538624-34-8

Oxibendazole-amine HCl

1538624-34-8
1448346-35-7

Oxibendazole-amine-(propoxy D7)

1448346-35-7
6233-83-6

Oxytocin Acetate

6233-83-6
4682-36-4

Orphenadrine citrate

4682-36-4
18637-83-7

1,1'-Oxalyldiimidazole

18637-83-7
23696-28-8

Olaquindox

23696-28-8
16773-42-5

Ornidazole

16773-42-5
73986-53-5

O-Desmethyltramadol HCl

73986-53-5
129-20-4

Oxyphenbutazone

129-20-4
7060-74-4

Oleandomycin phosphate

7060-74-4
76738-62-0

Paclobutrazol

76738-62-0
66246-88-6

Penconazole

66246-88-6